Search Content | UT Health San Antonio MD Anderson Cancer Center

Search Result for "*:*"

Research & Publications

Percutaneous BCG enhances innate effector antitumor cytotoxicity during treatment of bladder cancer: a translational clinical trial.

Research & Publications

Rapamycin Prevents Surgery-Induced Immune Dysfunction in Patients with Bladder Cancer.

provider

Joshua Asper, PA-C Physician Assistant

Research & Publications

Metastatic medulloblastoma in an adolescent with Simpson-Golabi-Behmel syndrome.

Research & Publications

A functional screen identifies miRNAs that inhibit DNA repair and sensitize prostate cancer cells to ionizing radiation.

Research & Publications

A novel approach for detecting viable and tissue-specific circulating tumor cells through an adenovirus-based reporter vector.

Cancer Treatment

Intensity-Modulated Radiation Therapy (IMRT)

At Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, our team pioneered the use of intensity-modulated radiation therapy (IMRT) decades ago. Today, our experts use IMRT to treat certain cancers, such as prostate and lung cancers, with incredible precision. IMRT’s increased effectiveness — with fewer side effects — offers new possibilities for what you can do during and after cancer treatment.

Research & Publications

Contemporary management of metastatic bone disease: tips and tools of the trade for general practitioners.

Research & Publications

A phase I study of the combination of temsirolimus with irinotecan for metastatic sarcoma.

Research & Publications